This is a descriptive study comprising two cohorts of esophageal cancer patients. The first cohort will be followed prospectively and will include patients newly diagnosed with esophageal cancer prior to treatment. QOL assessments will be administered pre-surgery, at first post-operative visit, and at 6 and 12 months post surgery. The second cohort will be a cross sectional sample and include patients more than 18 months post treatment, without evidence of disease who will undergo one QOL assessment. This is a preliminary investigation and it is hoped that we will be able to base future research questions on our results of this study.